{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T00:53:43Z","timestamp":1795049623262,"version":"4.10.2"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>As detection rates of non-albican<jats:italic toggle=\"yes\">s Candida<\/jats:italic> species are increasing, determining their pathogen profiles and antifungal susceptibilities is important for antifungal treatment selection. We identified the antifungal susceptibility patterns and predictive factors for mortality in candidemia.<\/jats:p>\n            <jats:p>A multicenter retrospective analysis of patients with at least 1 blood culture positive for <jats:italic toggle=\"yes\">Candida<\/jats:italic> species was conducted. <jats:italic toggle=\"yes\">Candida<\/jats:italic> species were classified into 3 groups (group A, <jats:italic toggle=\"yes\">Candia albicans<\/jats:italic>; group B, <jats:italic toggle=\"yes\">Candida tropicalis<\/jats:italic>, and <jats:italic toggle=\"yes\">Candida parasilosis<\/jats:italic>; group C, <jats:italic toggle=\"yes\">Candida glabrata<\/jats:italic> and <jats:italic toggle=\"yes\">Candida krusei<\/jats:italic> ) to analyze the susceptibility patterns, first-line antifungal administered, and mortality. Univariate and multivariate comparisons between outcomes were performed to identify mortality risk factors.<\/jats:p>\n            <jats:p>In total, 317 patients were identified, and 136 (42.9%) had recorded mortality. Echinocandin susceptibility was higher for group A than group B (111\/111 [100%] vs 77\/94 [81.9%], <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a.001). Moreover, group A demonstrated higher fluconazole susceptibility (144\/149 [96.6%] vs 39\/55 [70.9%], <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a.001) and lower mortality (68 [45.3%] vs 34 [61.8%], <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.036) than those of group C. In the multivariate analysis, the sequential organ failure assessment score (odds ratio OR 1.351, 95% confidence interval 1.067\u20131.711, <jats:italic toggle=\"yes\">p<\/jats:italic>\u200a=\u200a0.013) and positive blood culture on day 7 of hospitalization (odds ratio 5.506, 95% confidence interval, 1.697\u201317.860, <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.004) were associated with a higher risk of mortality.<\/jats:p>\n            <jats:p>Patients with higher sequential organ failure assessment scores and sustained positive blood cultures have an increased risk of mortality.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000019494","type":"journal-article","created":{"date-parts":[[2020,3,16]],"date-time":"2020-03-16T06:53:55Z","timestamp":1584341635000},"page":"e19494","source":"Crossref","is-referenced-by-count":16,"title":["A multicenter retrospective analysis of the antifungal susceptibility patterns of Candida species and the predictive factors of mortality in South Korean patients with candidemia"],"prefix":"10.1097","volume":"99","author":[{"given":"In Young","family":"Jung","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Yonsei University Wonju College of Medicine, Wonju, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su Jin","family":"Jeong","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and AIDS Research Institute, Yonsei University College of Medicine, Seoul, South Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Keun","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Yonsei University Wonju College of Medicine, Wonju, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyo Youl","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Yonsei University Wonju College of Medicine, Wonju, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Goo","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and AIDS Research Institute, Yonsei University College of Medicine, Seoul, South Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"June Myung","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and AIDS Research Institute, Yonsei University College of Medicine, Seoul, South Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun Yong","family":"Choi","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and AIDS Research Institute, Yonsei University College of Medicine, Seoul, South Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,3]]},"reference":[{"key":"R1-20230915","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/civ933","article-title":"Clinical practice guideline for the management of Candidiasis: 2016 update by the Infectious Diseases Society of America","volume":"62","author":"Pappas","year":"2016","journal-title":"Clin Infect Dis"},{"key":"R2-20230915","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1086\/497138","article-title":"The changing face of fungal infections in health care settings","volume":"41","author":"Fridkin","year":"2005","journal-title":"Clin Infect Dis"},{"key":"R3-20230915","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1056\/NEJMra1315399","article-title":"Invasive candidiasis","volume":"373","author":"Kullberg","year":"2015","journal-title":"N Engl J Med"},{"key":"R4-20230915","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1097\/CCM.0b013e31816fc4cd","article-title":"Risk factors for albicans and non-albicans candidemia in the intensive care unit","volume":"36","author":"Chow","year":"2008","journal-title":"Crit Care Med"},{"key":"R5-20230915","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1086\/599039","article-title":"Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry","volume":"48","author":"Horn","year":"2009","journal-title":"Clin Infect Dis"},{"key":"R6-20230915","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1128\/JCM.44.5.1782-1787.2006","article-title":"International surveillance of Candida spp. and Aspergillus spp.: report from the SENTRY antimicrobial surveillance program (2003)","volume":"44","author":"Messer","year":"2006","journal-title":"J Clin Microbiol"},{"key":"R7-20230915","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1128\/JCM.02363-09","article-title":"Antifungal susceptibility testing of Candida isolates from the Candida surveillance study","volume":"48","author":"Lyon","year":"2010","journal-title":"J Clin Microbiol"},{"key":"R8-20230915","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/599376","article-title":"Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America","volume":"49","author":"Mermel","year":"2009","journal-title":"Clin Infect Dis"},{"key":"R9-20230915","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1093\/jac\/dkr511","article-title":"Timing of susceptibility-based antifungal drug administration in patients with Candida bloodstream infection: correlation with outcomes","volume":"67","author":"Grim","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"R10-20230915","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.drup.2011.01.004","article-title":"Clinical breakpoints for the echinocandins and Candida revisited: Integration of molecular, clinical, and microbiological data to arrive at species-specific interpretive criteria","volume":"14","author":"Pfaller","year":"2011","journal-title":"Drug Resist Updat"},{"key":"R13-20230915","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.jiac.2018.09.016","article-title":"Changing epidemiology of non-albicans candidemia in Korea","volume":"25","author":"Ko","year":"2019","journal-title":"J Infect Chemother"},{"key":"R14-20230915","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.3201\/eid2410.180649","article-title":"Candida auris in healthcare facilities, New York, USA, 2013\u20132017","volume":"24","author":"Adams","year":"2018","journal-title":"Emerg Infect Dis"},{"key":"R15-20230915","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1093\/cid\/cix744","article-title":"Approach to the investigation and management of patients with Candida auris, an emerging multidrug-resistant yeast","volume":"66","author":"Tsay","year":"2018","journal-title":"Clin Infect Dis"},{"key":"R16-20230915","doi-asserted-by":"crossref","first-page":"3139","DOI":"10.1128\/JCM.00319-11","article-title":"First three reported cases of nosocomial fungemia caused by Candida auris","volume":"49","author":"Lee","year":"2011","journal-title":"J Clin Microbiol"},{"key":"R17-20230915","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/myc.12330","article-title":"Antifungal drug resistance among Candida species: mechanisms and clinical impact","volume":"58","author":"Sanguinetti","year":"2015","journal-title":"Mycoses"},{"key":"R18-20230915","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.drup.2010.09.002","article-title":"Wild-type MIC distributions, epidemiological cutoff values and species-specific clinical breakpoints for fluconazole and Candida: time for harmonization of CLSI and EUCAST broth microdilution methods","volume":"13","author":"Pfaller","year":"2010","journal-title":"Drug Resist Updat"},{"key":"R19-20230915","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1128\/JCM.01915-07","article-title":"Candida krusei, a multidrug-resistant opportunistic fungal pathogen: geographic and temporal trends from the ARTEMIS DISK antifungal surveillance program, 2001 to 2005","volume":"46","author":"Pfaller","year":"2008","journal-title":"J Clin Microbiol"},{"key":"R20-20230915","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.drup.2011.01.004","article-title":"Clinical breakpoints for the echinocandins and Candida revisited: integration of molecular, clinical, and microbiological data to arrive at species-specific interpretive criteria","volume":"14","author":"Pfaller","year":"2011","journal-title":"Drug Resist Updat"},{"key":"R21-20230915","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.diagmicrobio.2012.10.003","article-title":"Epidemiology and outcomes of candidemia in 3648 patients: data from the Prospective Antifungal Therapy (PATH Alliance\u00ae) registry, 2004\u20132008","volume":"74","author":"Pfaller","year":"2012","journal-title":"Diagn Microbiol Infect Dis"},{"key":"R22-20230915","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1093\/cid\/cis021","article-title":"Impact of treatment strategy on outcomes in patients with candidemia and other forms of invasive candidiasis: a patient-level quantitative review of randomized trials","volume":"54","author":"Andes","year":"2012","journal-title":"Clin Infect Dis"},{"key":"R23-20230915","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jinf.2012.11.002","article-title":"Risk factors and outcomes of Candida krusei bloodstream infection: a matched, case-control study","volume":"66","author":"Schuster","year":"2013","journal-title":"J Infect"},{"key":"R24-20230915","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1093\/cid\/cit006","article-title":"Finding the \u201cmissing 50%\u201d of invasive candidiasis: how nonculture diagnostics will improve understanding of disease spectrum and transform patient care","volume":"56","author":"Clancy","year":"2013","journal-title":"Clin Infect Dis"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000019494","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T23:57:07Z","timestamp":1694822227000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000019494"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":22,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000019494","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3]]}}}